Upcoming event

Quality of life in previously untreated patients with advanced renal cell carcinoma (aRCC) in CheckMate 214: updated results

, September 2019

Advanced clear-cell renal cell carcinoma (accRCC): association of microRNAs (miRNAs) with molecular subtypes, mRNA targets and outcome

September 2019

First-line pembrolizumab (pembro) monotherapy for advanced non‒clear cell renal cell carcinoma (nccRCC): updated follow-up for keynote-427 cohort b

September 2019

Prior tyrosine kinase inhibitors (TKI) and antibiotics (ATB) use are associated with distinct gut microbiota guilds in renal cell carcinoma (RCC) patients

September 2019

Tumour seeding in the tract of percutaneous renal tumour biopsy: a report on seven cases from a UK tertiary referral centre

European Urology, Volume 75, Issue 5, May 2019, Pages 861-867

The ERUS curriculum for robot-assisted partial nephrectomy: structure definition and pilot clinical validation

European Urology, Volume 75, Issue 6, June 2019, Pages 1023-1031

Intensive imaging-based follow-up of surgically treated localised renal cell carcinoma does not improve post-recurrence survival: results from a European Multicentre Database (RECUR)

European Urology, Volume 75, Issue 2, February 2019, Pages 261-264

Stereotactic radiotherapy for stage I renal cell carcinoma: Overall survival and treatment trends compared to thermal ablation and surgical resection

May 2019

Cardiovascular mortality in renal cell carcinoma: A population-based study

May 2019

Unraveling the molecular profile underpinning pancreatic tropisms in metastatic clear cell renal cell carcinoma

May 2019

Randomized, double-blind phase III study of pazopanib versus placebo in patients with metastatic renal cell carcinoma who have no evidence of disease following metastasectomy: A trial of the ECOG-ACRIN cancer research group (E2810)

May 2019

Testing the external validity of CARMENA trial comparing sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma

PreviousNext